Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.

The American journal of cardiology - 15 Sept 2016

van Velzen Hannah G, Vriesendorp Pieter A, Oldenburg Rogier A, van Slegtenhorst Marjon A, van der Velden Jolanda, Schinkel Arend F L, Michels Michelle

Abstract excerpt

Pathogenic gene mutations are found in about 50% of patients with hypertrophic cardiomyopathy (HC). Previous studies have shown an association between sarcomere mutations and medium-term outcome. The association with long-term outcome has not been described. The aim of this cohort study was to assess the long-term outcomes of patients with genotype positive (G+) and genotype negative (G-) HC. The study population...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Myosins
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cause of Death

Share to Death, Sudden, Cardiac

Share to Heart Failure

Share to Mortality

Share to Myosin Heavy Chains

Share to Myosin Light Chains

Source

Identifiers

PMID: 27476098
DOI: 10.1016/j.amjcard.2016.06.038

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.PMID 27476098Read ↗

The Long-Term Clinical Progression of Genotype-Positive/Phenotype-Negative Patients With Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Role of Genetic Testing in Diagnosis and Prognosis Prediction in Hypertrophic Cardiomyopathy in Korea.Semantic proximity Read ↗

Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Family screening for hypertrophic cardiomyopathy: initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individualsSemantic proximity Read ↗

Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification.Semantic proximity Read ↗

Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathySemantic proximity Read ↗

Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the FutureSemantic proximity Read ↗

Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.Semantic proximity Read ↗

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.